ArticleJAMA network open2024

Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk in Patients With Type 2 Diabetes.

Rachel Dankner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.